First targeted treatment to reduce the risk of ALK positive lung cancer returning after complete tumour removal recommended ...

People have the right to be able to make informed decisions about their care. Our guidance should be taken into account when making decisions with them. We're working with other leading health ...

Proposals for a phased launch of the obesity injection tirzepatide have been set out, as a consultation begins. NHS England ...

All NICE products on COVID-19. Includes any guidance and advice.

The new modifier was introduced in 2022 to allow extra weight to be given to medicines that address severe diseases. It ...

Demand for NHS Talking Therapies has reached an all-time high. The service received 1.82 million referrals in 2023/24. This is slightly higher than 2021/2022, and more than double the 884,000 received ...

We use the best available evidence to develop recommendations that guide decisions in health, public health and social care.

We use the best available evidence to develop recommendations that guide decisions in health, public health and social care.

All NICE products on people with learning disabilities. Includes any guidance and quality standards.

This webpage covers all NICE’s guidelines on mental health. The table presents the guidelines alphabetically. Updates planned or in progress and areas we’re actively monitoring are listed for each ...

This webpage covers all NICE’s guidelines on women’s and reproductive health. The table presents the guidelines alphabetically. Updates planned or in progress and areas we’re actively monitoring are ...